JPH11505701A - プロスタグランジン受容体fp及び該受容体をコードするdna - Google Patents
プロスタグランジン受容体fp及び該受容体をコードするdnaInfo
- Publication number
- JPH11505701A JPH11505701A JP7502269A JP50226995A JPH11505701A JP H11505701 A JPH11505701 A JP H11505701A JP 7502269 A JP7502269 A JP 7502269A JP 50226995 A JP50226995 A JP 50226995A JP H11505701 A JPH11505701 A JP H11505701A
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- protein
- cells
- cdna
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. プロスタグランジンに特異的に結合する、単離し精製されたプロスタグラ ンジンFP受容体。 2. 前記受容体のタンパク質が下記のアミノ酸配列: を有することを特徴とする、請求項1に記載の単離し精製されたプロスタグラン ジン受容体タンパク質。 3. プロスタグランジン受容体タンパク質をコードする単離し精製されたDN A分子であって、前記タンパク質が請求項2に記載のアミノ酸配列を有すること を特徴とする前記DNA分子。 4. プロスタグランジン受容体タンパク質をコードする単離し精製されたDN A分子であって、下記のヌクレオチド配列: を有することを特徴とする前記DNA分子。 5. 組換え宿主細胞内でプロスタグランジン受容体タンパク質を発現させるた めの発現ベクターであって、請求項4に記載のDNA分子を含む前記発現ベクタ ー。 6. 組換えプロスタグランジン受容体タンパク質を発現する宿主細胞であって 、請求項5に記載の発現ベクターを含む前記宿主細胞。 7. 組換え宿主細胞内でプロスタグランジン受容体タンパク質を発現させる方 法であって、(a)請求項5に記載の発現ベクターを適当な宿主細胞内にトラン スファーし、(b)ステップ(a)の宿主細胞を発現ベクターからのプロスタグ ランジン受容体タンパク質の発現を可能にする条件下で培養する操作を含む前記 方法。 8. プロスタグランジン受容体活性の調節因子を同定する方法であって、(a )プロスタグランジン受容体活性の調節因子を、請求項2に記載のアミノ酸配列 の全体又は部分を有することを特徴とするプロスタグランジン受容体と混合し、 (b)プロスタグランジン受容体に対する調節因子の作用を測定する操作を含む 前記方法。 9. プロスタグランジン受容体タンパク質に特異的に結 合する抗体であって、前記タンパク質が請求項2に記載のアミノ酸配列を有する ことを特徴とする前記抗体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US083,741 | 1987-08-07 | ||
US08/083,741 US5869281A (en) | 1993-06-25 | 1993-06-25 | DNA encoding prostaglandin receptor FP |
PCT/CA1994/000319 WO1995000551A1 (en) | 1993-06-25 | 1994-06-09 | Prostaglandin receptor fp and dna encoding it |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11505701A true JPH11505701A (ja) | 1999-05-25 |
JP3228751B2 JP3228751B2 (ja) | 2001-11-12 |
Family
ID=22180389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50226995A Expired - Fee Related JP3228751B2 (ja) | 1993-06-25 | 1994-06-09 | プロスタグランジン受容体fp及び該受容体をコードするdna |
Country Status (9)
Country | Link |
---|---|
US (3) | US5869281A (ja) |
EP (1) | EP0705276B1 (ja) |
JP (1) | JP3228751B2 (ja) |
AT (1) | ATE170532T1 (ja) |
AU (1) | AU6991894A (ja) |
CA (1) | CA2165954C (ja) |
DE (1) | DE69413039T2 (ja) |
ES (1) | ES2120052T3 (ja) |
WO (1) | WO1995000551A1 (ja) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202892D0 (sv) | 1992-10-02 | 1992-10-02 | Kabi Pharmacia Ab | Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
US6057433A (en) * | 1993-11-19 | 2000-05-02 | Allergan Sales, Inc. | Nucleic acid encoding human EP3 prostaglandin receptor |
US6670134B1 (en) | 1993-11-19 | 2003-12-30 | Allergan, Inc. | Human EP3 prostaglandin receptor |
US7294331B2 (en) | 1994-03-07 | 2007-11-13 | Immunex Corporation | Methods of using flt3-ligand in hematopoietic cell transplantation |
WO1996023066A2 (en) | 1995-01-26 | 1996-08-01 | Merck Frosst Canada Inc. | Prostaglandin receptor, dp |
US5955575A (en) * | 1997-12-22 | 1999-09-21 | Hopital Sainte-Justine | Antagonists of G-protein-coupled receptor |
US6984719B1 (en) | 1998-09-17 | 2006-01-10 | Hospital Sainte-Justine | Peptide antagonists of prostaglandin F2α receptor |
AU5722499A (en) | 1998-09-17 | 2000-04-10 | Hopital Sainte-Justine | G protein-coupled receptor agonists or antagonists |
WO2000029614A1 (en) * | 1998-11-12 | 2000-05-25 | Gemini Genomics Ab. | Human prostaglandin receptors and methods of use thereof |
ES2232434T3 (es) | 1999-03-05 | 2005-06-01 | Duke University | Analogos de prostaglandinas c-16 fp selectivas insaturadas. |
US6894175B1 (en) * | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
MXPA02005626A (es) | 1999-12-06 | 2004-09-10 | Pital Sainte Justine H | Composiciones para el tratamiento de filtracion glomerular, conductos arteriosos y osteoporosis del paciente. |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020172693A1 (en) * | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
DE60236951D1 (de) * | 2001-05-21 | 2010-08-19 | Fujifilm Corp | Vorrichtung zur Durchführung biochemischer Analysen und Verfahren zu ihrer Herstellung |
US7521530B2 (en) | 2002-06-11 | 2009-04-21 | Universite De Montreal | Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor |
WO2004073590A2 (en) * | 2003-02-24 | 2004-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for deseases associated with g-protein coupled receptor prostaglandin f2-alpha (prostaglandin f2-alpha) |
US7320871B2 (en) * | 2003-07-14 | 2008-01-22 | Allergan, Inc. | Human prostaglandin FP receptor variants and methods of using same |
US20050074847A1 (en) * | 2003-10-07 | 2005-04-07 | Yanbin Liang | Human prostaglandin EP1 receptor variants and methods of using same |
US20050084929A1 (en) * | 2003-10-17 | 2005-04-21 | Yanbin Liang | Human prostaglandin EP4 receptor variants and methods of using same |
US20050084931A1 (en) * | 2003-10-20 | 2005-04-21 | Yanbin Liang | Human prostaglandin DP receptor variants and methods of using same |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9202892D0 (sv) * | 1992-10-02 | 1992-10-02 | Kabi Pharmacia Ab | Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
-
1993
- 1993-06-25 US US08/083,741 patent/US5869281A/en not_active Expired - Lifetime
-
1994
- 1994-06-09 AU AU69918/94A patent/AU6991894A/en not_active Abandoned
- 1994-06-09 EP EP94918699A patent/EP0705276B1/en not_active Expired - Lifetime
- 1994-06-09 AT AT94918699T patent/ATE170532T1/de not_active IP Right Cessation
- 1994-06-09 ES ES94918699T patent/ES2120052T3/es not_active Expired - Lifetime
- 1994-06-09 DE DE69413039T patent/DE69413039T2/de not_active Expired - Lifetime
- 1994-06-09 CA CA002165954A patent/CA2165954C/en not_active Expired - Fee Related
- 1994-06-09 JP JP50226995A patent/JP3228751B2/ja not_active Expired - Fee Related
- 1994-06-09 WO PCT/CA1994/000319 patent/WO1995000551A1/en active IP Right Grant
-
1997
- 1997-11-21 US US08/976,074 patent/US5840847A/en not_active Expired - Lifetime
- 1997-11-21 US US08/976,166 patent/US6358694B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6358694B1 (en) | 2002-03-19 |
US5840847A (en) | 1998-11-24 |
AU6991894A (en) | 1995-01-17 |
CA2165954C (en) | 2005-04-26 |
WO1995000551A1 (en) | 1995-01-05 |
JP3228751B2 (ja) | 2001-11-12 |
US5869281A (en) | 1999-02-09 |
ES2120052T3 (es) | 1998-10-16 |
CA2165954A1 (en) | 1995-01-05 |
ATE170532T1 (de) | 1998-09-15 |
DE69413039T2 (de) | 1999-05-06 |
EP0705276A1 (en) | 1996-04-10 |
DE69413039D1 (de) | 1998-10-08 |
EP0705276B1 (en) | 1998-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11505701A (ja) | プロスタグランジン受容体fp及び該受容体をコードするdna | |
JP3118460B2 (ja) | プロスタグランジンレセプターep▲下2▼をコードするdna | |
JP3029125B2 (ja) | プロスタグランジンレセプターipをコードするdna | |
US5824504A (en) | Human 7-transmembrane receptor and DNA | |
JP3064015B2 (ja) | プロスタグランジンレセプターdp | |
JPH10262687A (ja) | 新規ヒト11cbスプライス変種 | |
US6440680B1 (en) | Methods of identifying modulators of prostaglandin receptor EP1 | |
JPH10295376A (ja) | ヒトgpr14レセプターのクローニング | |
PL179196B1 (pl) | wyizolowane skrócone bialko kinazy receptorowej BMP,zrekombinowane wektory ekspresyjne komórki gospodarzy,ssacze komórki gospodarzy, sposób wytwarzania skróconego bialka kinazy receptoro-wej BMP, sposób identyfikowania zwiazków oraz sposób otrzymywania przeciwcial PL PL PL PL | |
JP3343258B2 (ja) | プロスタグランジン受容体ep▲3▼及び該受容体をコードするdna | |
JP2001506481A (ja) | ブラジキニンb▲下1▼レセプターをコードするdna | |
US5912335A (en) | G-protein coupled receptor HUVCT36 | |
ES2281355T3 (es) | Adn que codifica una subunidad humana 5-ht3-c del receptor de serotonina 5-ht3. | |
JP2004500085A (ja) | ヒトバニロイドレセプターvr3をコードするdna | |
JP3090472B2 (ja) | プロスタグランジン受容体ep▲下1▼をコードするdna | |
US20040116669A1 (en) | Prostaglandin ep1 receptor | |
JPH1175866A (ja) | マウスFrizzled−6 遺伝子に類似したヒト7TM受容体 | |
JPH10304887A (ja) | 新規g−タンパク質結合性レセプター(htadx50) | |
JP2002501382A (ja) | GABA−A受容体のヒトθサブユニット | |
EP0837128A2 (en) | Human G-protein coupled receptor, HLYAZ61 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070907 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080907 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080907 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090907 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100907 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100907 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110907 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |